Diabetes Dilemmas: CGM, A1c Measurements, & New Management Strategies
Continuous glucose monitors (CGM) continually monitor the glucose in blood through an external device attached to the body. Measurement of A1c provides a measure of the average blood glucose for the previous 3 months but it does not document highs and lows. CGM provides information over a period of 7-14 days but A1c is still considered the gold standard for determining long-term diabetes control.
There are currently varying medical opinions regarding CGM and A1c measurements, discordance between values, cost, and point-of-care impact on patient outcomes. In this webinar, Dr. Melissa Putman, Director of the Diabetes Research Center at Massachusetts General Hospital, diabetes educator and pharmacist, Dr. Heather Whitley of Auburn University, and Dr. James Nichols, Medical Director of Clinical Chemistry and Point-of-Care Testing at Vanderbilt University will discuss those questions and provide information on the use of CGM and A1c for patients with diabetes.
This webinar is accredited for a total of 1.5 hours of credit for physicians, nurses, laboratory professionals, pharmacists, and diabetes educators. Each part of the webinar is 0.5 credit hours. To receive full credit, please view all three parts and complete the evaluation below.
Part 1: Continuous Glucose Monitoring and HbA1c in Clinical Practice
Part 2: New Strategies and Emerging Trends in Diabetes Management
Part 3: Point-of-Care HbA1c Testing and Quality Control Measures
There are currently varying medical opinions regarding CGM and A1c measurements, discordance between values, cost, and point-of-care impact on patient outcomes. In this webinar, Dr. Melissa Putman, Director of the Diabetes Research Center at Massachusetts General Hospital, diabetes educator and pharmacist, Dr. Heather Whitley of Auburn University, and Dr. James Nichols, Medical Director of Clinical Chemistry and Point-of-Care Testing at Vanderbilt University will discuss those questions and provide information on the use of CGM and A1c for patients with diabetes.
This webinar is accredited for a total of 1.5 hours of credit for physicians, nurses, laboratory professionals, pharmacists, and diabetes educators. Each part of the webinar is 0.5 credit hours. To receive full credit, please view all three parts and complete the evaluation below.
Part 1: Continuous Glucose Monitoring and HbA1c in Clinical Practice
Part 2: New Strategies and Emerging Trends in Diabetes Management
Part 3: Point-of-Care HbA1c Testing and Quality Control Measures
Part 1
Part 2
Part 3
Downloads
Section 1: “The Discordance Seen in CGM/A1c Measurements”
Melissa Putman, MD
Director, Diabetes Research Center
Massachusetts General Hospital
Assistant Professor
Harvard Medical School
Boston, Massachusetts
Dr. Putman is board certified in internal medicine, pediatrics, adult endocrinology and pediatric endocrinology. She sees patients and participates in clinical research in the Divisions of Endocrinology at Boston Children’s Hospital and Massachusetts General Hospital. Her primary research goal is improving the care of children and young adults with chronic diseases to prevent the endocrine complications that may significantly affect their future adult lives. She is a clinician investigator, assistant professor, and associate physician of the diabetes department at Massachusetts General Research Institute and Hospital, and Harvard Medical School.
Section 2: “New Strategies For Glycemic Control in Disadvantaged Populations”
Heather P. Whitley, PharmD, BCPS, CDE
Clinical Professor
Auburn University
Harrison School of Pharmacy
Auburn, Alabama
Heather Whitley, Pharm.D., BCPS is a Clinical Professor in the Department of Pharmacy Practice at Auburn University Harrison School of Pharmacy. She completed her Doctor of Pharmacy degree from the Medical University of South Carolina in 2004, a Pharmacy Practice residency in 2005, and a Primary Care residency in 2006, both of which were ASHP-accredited residency programs. She is also a Board Certified Pharmacotherapy Specialist (BCPS) and a Certified Diabetes Educator.
She has practiced in multiple locations in Alabama as a Clinical Pharmacy Diabetes Specialist, including family medicine practices in the rural Black Belt, FQHC facilities, and most recently a family medicine residency program in Montgomery Alabama, affiliated with Baptist Health System. For the duration of her career she has been faculty with the Auburn University Harrison School of Pharmacy.
Dr. Whitley has published more than 30 manuscripts and presented at the national and international arena predominantly on her diabetes related research. Her research includes diagnostic measures, diabetes care and the chronic care model, and the scholarship of teaching and learning, particularly as it involves provision of care at camps for children with type 1 diabetes.
Dr. Whitley is also closely involved with the Southeastern Diabetes Education Services by supporting Camp Seale Harris as an on-site pharmacist for years. There she cares for children with type 1 diabetes at over-night camps while teaching her pharmacy students on site.
She has practiced in multiple locations in Alabama as a Clinical Pharmacy Diabetes Specialist, including family medicine practices in the rural Black Belt, FQHC facilities, and most recently a family medicine residency program in Montgomery Alabama, affiliated with Baptist Health System. For the duration of her career she has been faculty with the Auburn University Harrison School of Pharmacy.
Dr. Whitley has published more than 30 manuscripts and presented at the national and international arena predominantly on her diabetes related research. Her research includes diagnostic measures, diabetes care and the chronic care model, and the scholarship of teaching and learning, particularly as it involves provision of care at camps for children with type 1 diabetes.
Dr. Whitley is also closely involved with the Southeastern Diabetes Education Services by supporting Camp Seale Harris as an on-site pharmacist for years. There she cares for children with type 1 diabetes at over-night camps while teaching her pharmacy students on site.
Section 3: “Point-of-Care A1c Testing & Quality Control Measures”
James H. Nichols, PhD, DABCC, FAACC
Professor of Pathology, Microbiology and Immunology
Medical Director of Clinical Chemistry and Point-of-Care Testing
Vanderbilt University Medical Center
Nashville, Tennessee
Medical Director of Clinical Chemistry and Point-of-Care Testing
Vanderbilt University Medical Center
Nashville, Tennessee
James H. Nichols, Ph.D., DABCC, FAACC is a Professor of Pathology, Microbiology, and Immunology, Medical Director of Clinical Chemistry and Point-of-Care Testing, and Medical Director of Special Testing at Vanderbilt University Medical Center in Nashville, TN. Dr. Nichols received his B.A. in General Biology/Premedicine from Revelle College, University of California at San Diego.
He went on to complete a Master’s and Doctorate in Biochemistry from the University of Illinois, Urbana-Champaign. Jim was a fellow in the Postdoctoral Training Program in Clinical Chemistry at the Mayo Clinic, Rochester, MN. He is board certified in both Clinical Chemistry and Toxicological Chemistry by the American Board of Clinical Chemistry.
Dr. Nichols spent several years as Associate Director of Clinical Chemistry, Director of Point-of-Care Testing, and an Associate Professor of Pathology at Johns Hopkins Medical Institutions. Jim later served as Medical Director of Clinical Chemistry for Baystate Health in Springfield, MA and was a Professor of Pathology at Tufts University School of Medicine.
Dr. Nichols is currently the President-Elect for the Clinical and Laboratory Standards Institute (CLSI). Dr. Nichols’ research interests span evidence-based medicine, information management, laboratory automation, point-of-care testing and toxicology.
He went on to complete a Master’s and Doctorate in Biochemistry from the University of Illinois, Urbana-Champaign. Jim was a fellow in the Postdoctoral Training Program in Clinical Chemistry at the Mayo Clinic, Rochester, MN. He is board certified in both Clinical Chemistry and Toxicological Chemistry by the American Board of Clinical Chemistry.
Dr. Nichols spent several years as Associate Director of Clinical Chemistry, Director of Point-of-Care Testing, and an Associate Professor of Pathology at Johns Hopkins Medical Institutions. Jim later served as Medical Director of Clinical Chemistry for Baystate Health in Springfield, MA and was a Professor of Pathology at Tufts University School of Medicine.
Dr. Nichols is currently the President-Elect for the Clinical and Laboratory Standards Institute (CLSI). Dr. Nichols’ research interests span evidence-based medicine, information management, laboratory automation, point-of-care testing and toxicology.